Systematic review and meta-analysis of maternal disease control and pregnancy outcomes with anti-CD20 therapy versus natalizumab in multiple sclerosis

Researchers from the College of Medicine at King Saud Bin Abdulaziz University for Health and Sciences (Riyadh, Saudi Arabia) have produced a systematic review and meta-analysis examining the efficacy and safety of anti-CD20 therapy in the setting of maternal multiple sclerosis in pregnancy. More information is available here.

Photo by Tara Winstead